Daniel Tardiff
Chief Scientific Officer at Camp4 Therapeutics Corp (CAMP) since October 2025
Daniel Tardiff has filed 4 insider reports with the SEC since October 2025, as chief Scientific Officer at Camp4 Therapeutics Corp (CAMP). In the last 12 months Daniel Tardiff sold $8,273 of stock on the open market. In the latest filing, on August 20, 2026, Daniel Tardiff sold 1,738 shares of Camp4 Therapeutics Corp (CAMP) for $8,273 at an average of $4.76.
- Filings
- 4
- Companies
- 1
- Bought on market
- None
- Sold on market
- $8,273
Companies where Daniel Tardiff is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Scientific Officersince October 2025 | 0 | $8,273 | $4.09 | Aug 20, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 19, 2026-$8,273CAMPChief Scientific Officer Tardiff Daniel sold $8,273 worth of shares (1,738 units at $4.76), closing all direct ownership in the companyForm 4Open-market sale
- Apr 1, 2026CAMPSEC Form 4 filed by Tardiff DanielForm 4Grant or award
- Dec 11, 2025CAMPSEC Form 4 filed by Chief Scientific Officer Tardiff DanielForm 4Grant or award
- Oct 1, 2025CAMPDaniel Tardiff became an insiderForm 3New insider
Compare Daniel Tardiff with
- Daniel Tardiff vs Kelly Gold1 shared
- Daniel Tardiff vs Andrew J. Schwab1 shared
- Daniel Tardiff vs Richard A Young1 shared
- Daniel Tardiff vs Yuri Maricich1 shared
- Daniel Tardiff vs Josh Mandel-Brehm1 shared
- Daniel Tardiff vs Douglas E Williams1 shared
Other insiders at the same companies
- Kelly GoldCAMP
- Andrew J. SchwabCAMP
- 5AM Partners VI, LLCCAMP
- Richard A YoungCAMP
- Yuri MaricichCAMP
- Josh Mandel-BrehmCAMP
- Douglas E WilliamsCAMP
- Steven H HoltzmanCAMP
- Murray StewartCAMP
- Amir NashatCAMP
- Michael F MacLeanCAMP
- Polaris Management Co. VII, L.L.C.CAMP
- James P BoylanCAMP
- Michael J HigginsCAMP
- Paula RaganCAMP
- Ravi I. ThadhaniCAMP
Questions about Daniel Tardiff
- What is Daniel Tardiff's role at Camp4 Therapeutics Corp?
- Daniel Tardiff reports to the SEC as chief Scientific Officer at Camp4 Therapeutics Corp (CAMP), according to the latest filing on August 20, 2026.
- Has Daniel Tardiff bought or sold stock recently?
- The most recent open-market sale was on August 19, 2026: sold 1,738 shares of Camp4 Therapeutics Corp (CAMP) for $8,273 at an average of $4.76.
- How do I get alerts when Daniel Tardiff files?
- Follow Daniel Tardiff on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Daniel Tardiff filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Daniel Tardiff (SEC CIK 0002089301). Totals count each trade once, skipping amendments whose original is on file, from Oct 10, 2025 on. View on SEC EDGAR